Search for: "Hoffmann-La Roche" Results 121 - 140 of 180
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jul 2010, 6:48 pm
Hoffmann-La Roche, Ltd., 580 F.3d 1340, 1374 (Fed. [read post]
29 Jul 2010, 5:00 am by Bexis
Hoffmann-La Roche Inc., 892 A.2d 694, (N.J. [read post]
21 Jun 2010, 9:57 am
They ask as follows: "(i) Are Article 7(2) of [the repealed and re-enacted but regularly cited] Council Directive 89/104 ... to approximate the laws of the Member States relating to trade marks and the associated case-law, in particular the judgments of the Court of Justice in Cases 102/77 Hoffmann-La Roche v Centrafarm and 1/81 Pfizer v Eurim-Pharm and Joined Cases C-427/93, C-429/93 and C-436/93 Bristol-Myers Squibb and Others v Paranova, to be interpreted as… [read post]
3 Jun 2010, 1:37 pm by Bexis
Hoffmann-La Roche Inc., 892 A.2d 694, 705 (N.J. [read post]
14 Apr 2010, 9:42 am by Geoffrey Manne
(In Europe, for example, the Commission’s decision, citing to EU case law (its Hoffmann-La Roche line of cases), essentially refused to acknowledge that there could be any pro-competitive justifications for Intel’s discounts. [read post]
14 Apr 2010, 5:30 am by The Docket Navigator
In denying defendant's motion to transfer venue, the court rejected the argument that plaintiff's decision to locate its office in the Eastern District of Texas was an attempt "to manipulate venue in anticipation of litigation," as prohibited by In re Hoffmann-La Roche, 587 F.3d 1333, 1337 (Fed. [read post]
11 Apr 2010, 9:36 pm by Patent Docs
LLC; Hoffmann-La Roche Inc. [read post]
24 Mar 2010, 11:33 am
Ariad sued Eli Lilly over 6,410,516. [read post]
2 Feb 2010, 7:28 am by Beck, et al.
Hoffmann-La Roche Inc., 392 F.Supp.2d 907, 919 (S.D. [read post]
30 Dec 2009, 2:00 am
(EPLAW) Thrombin JM - Pharma company avoids injunction by dropping competitive keyword ads: King v ZymoGenetics (Technology & Marketing Law Blog) Vytorin (Ezetimibe, Simvastatin) - US: Schering files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) Xeloda (Capecitabine) - US: Hoffmann-La Roche files patent infringement complaint against Roxane following Para IV challenge (Patent Docs)   [read post]
19 Dec 2009, 1:58 am
Hoffmann-La Roche, Ltd., 580 F.3d 1340, 1370 (Fed. [read post]
9 Dec 2009, 3:59 pm
(Patent Docs) Cialis (Tadalafil), Levitra (Vardenafil), Viagra (Sildenafil) - Israel Court releases impounded moped of impotence drug dealer: Israel Police Fraud Squad vs Gillert (IP Factor) Effexor XR (Venlafaxine) – Mylan announces settlement agreement related to antidepressant (SmartBrief) (GenericsWeb) Fuzeon (Enfuvirtide) – US: CAFC orders another case transferred out of Texas: In re Hoffmann-La Roche (Patently-O) Glumetza (Metformin) – US: Complaint… [read post]
28 Oct 2009, 7:15 am
Holdings v Metabolite Labs (Patent Baristas) US: BIO’s IPCC Conference: Patent re-examination in the life sciences (Patent Baristas) US: Senate Judiciary Committee passes amended Preserve Access to Affordable Generics Act (S.396) banning pay-for-delay settlements (Patent Baristas) US: TTOs wary of new recommendations from Task Force on IP and Genetic Testing that could weaken patent protection for genetic research (Technology Transfer Tactics) US: Empirical research fails to support gene… [read post]
28 Oct 2009, 6:15 am
Holdings v Metabolite Labs (Patent Baristas) US: BIO's IPCC Conference: Patent re-examination in the life sciences (Patent Baristas) US: Senate Judiciary Committee passes amended Preserve Access to Affordable Generics Act (S.396) banning pay-for-delay settlements (Patent Baristas) US: TTOs wary of new recommendations from Task Force on IP and Genetic Testing that could weaken patent protection for genetic research (Technology Transfer Tactics) US: Empirical research fails to support gene… [read post]
28 Oct 2009, 6:15 am
Holdings v Metabolite Labs (Patent Baristas) US: BIO's IPCC Conference: Patent re-examination in the life sciences (Patent Baristas) US: Senate Judiciary Committee passes amended Preserve Access to Affordable Generics Act (S.396) banning pay-for-delay settlements (Patent Baristas) US: TTOs wary of new recommendations from Task Force on IP and Genetic Testing that could weaken patent protection for genetic research (Technology Transfer Tactics) US: Empirical research fails to support gene… [read post]
8 Oct 2009, 6:05 am
Hoffmann-La Roche (Patent Docs) Razadyne (Galanthamine) - US: CAFC: You can’t rely on test results that weren’t available when your patent application was filed: Janssen Pharma and Synaptech v. [read post]